How many insider trades does FilingIQ track for MYNZ?

FilingIQ tracks 11 Form 4 insider transactions for MYNZ (Quantum Cyber N.V.), covering filings from Oct 17, 2025 onwards. 2 of those were filed in the last 90 days.

Are MYNZ insiders net buyers or net sellers?

Across the full Form 4 history for MYNZ, 2 transactions (18%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MYNZ insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MYNZ in?

Quantum Cyber N.V. (MYNZ) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $7.25M.

MYNZ insider trading

Healthcare

Quantum Cyber N.V. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

18% / 0%

Market cap

$7.25M

About Quantum Cyber N.V.

Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.

Company website: mainzbiomed.com

MYNZ insider activity at a glance

FilingIQ has scored 11 insider transactions for MYNZ since Oct 17, 2025. The most recent filing in our index is dated Apr 22, 2026.

Across the full history, 2 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MYNZ insider trades is 53.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MYNZ trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for MYNZ?: FilingIQ tracks 11 Form 4 insider transactions for MYNZ (Quantum Cyber N.V.), covering filings from Oct 17, 2025 onwards. 2 of those were filed in the last 90 days.
Are MYNZ insiders net buyers or net sellers?: Across the full Form 4 history for MYNZ, 2 transactions (18%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MYNZ insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MYNZ in?: Quantum Cyber N.V. (MYNZ) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $7.25M.

Methodology & sources

Every MYNZ insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.